Marco J.J.H. Grootenboers

Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism

Marc Righini, Josien van Es, Paul L. den Exter et al. · JAMA · 2014 · 914 citations · Full text

Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series

Antine Flikweert, Marco J.J.H. Grootenboers, David C.Y. Yick et al. · Journal of Critical Care · 2020 · 100 citations · Full text

Invasive Aspergillosis, Long Covid, Covid-19 Pandemic +6

No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis

Caroline E. Broos, Linda H.C. Poell, Caspar W. N. Looman et al. · Respiratory Medicine · 2017 · 89 citations

Fvc Change, Advanced Lung Disease, Clinical Epidemiology +9

Isolated Lung Perfusion With Melphalan for Resectable Lung Metastases: A Phase I Clinical Trial

Jeroen Hendriks, Marco J.J.H. Grootenboers, Franz M.N.H. Schramel et al. · The Annals of Thoracic Surgery · 2004 · 73 citations

Surgical Oncology, Medicine, Metronomic Therapy +8

Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients

Milou A.M. Stals, Marco J.J.H. Grootenboers, Coen van Guldener et al. · Research and Practice in Thrombosis and Haemostasis · 2021 · 70 citations · Full text